Five years after Covid-19 began to spread in the Chinese city of Wuhan, the cases of human metapneumovirus, which also reason breathing infections, have higher in the country, especially among children.
Between Dec. 23 and Dec. 29, the highest instances of HMPV since last week, especially in northern China and young people under 14, the Center for Disease Control and Prevention said on Thursday. Mycoplasma instances of influenza, rhinovirus, and pneumoniae also have higher rates.
Online videos of overcrowded hospitals in China are reminiscent of the early days of the CovVI-19 pandemic, and Google in the United States connected to the HMPV and the likelihood of an upcoming pandemic and lockdown has been higher in recent days.
But HMPV is not a risk for Covid-19 because it is not a new virus, which means that we perceive how it affects humans and that other people already have some opposing immunity.
HMPV reasons symptoms without blood, such as coughing, wheezing, nasal secretion and throat pain, which is transparent on their own within 3 to six days. But it can lead to more serious conditions, such as bronchitis or pneumonia, especially in young children, adults over 65 years and immunocompromised people. Infections are maximum non -unusual in the seasons without blood.
Most other people get HMPV before age 5, so symptoms tend to be more severe in young people because they haven’t built up immunity yet. A user gains some immunity to the virus when they are first caught, so symptoms are mild if they are reinfected.
Tos and sneezing are propagated, direct touch with an inflamed user or touching infected surfaces through the virus, such as phones.
There are no antiviral medications for HMPV, but if a patient becomes seriously ill, doctors would possibly use oxygen treatment to breathe or antibiotics to treat secondary infections. There is no vaccine, but there is one in development.
The HMPV first known in the Netherlands in 2001, but would have inflamed humans for decades.
“It’s very different from the CovVI-19 pandemic,” said Jill Carr, a virologist at Flinders University’s School of Medicine and Public Health in Australia.
“The virus absolutely new to humans and it emerged from an animal overflow and spread to pandemic titles because there is no prior exposure or protective immunity in the community,” Carr said of Covid-19.
There is a wide way in which HMPV spreads and affects humans, as well as diagnostic tests to identify it.
“HMPV can certainly make people very sick, and high case numbers are a threat to effective hospital services, but the current situation in China with high HMPV cases is very different to the threats initially posed by SARS-CoV-2 resulting in the COVID-19 pandemic,” Carr said.
A spokesman for the World Health Organization told Business Insider email that higher titles of respiratory diseases are expected, which HMPV added, at this time of the year, and added that the flu activity rate “decreased that the same time the same time last year.
On Thursday, Chinese CDCs begged other people to take precautions of fitness, such as maintain and use and use and use. Mask in overcrowded spaces.
But in a press conference on Friday, the Chinese government appeared to push back against online speculation that the situation could overwhelm hospitals and lead to a new pandemic, The Guardian reported.
“Respiratory infections tend to peak during the winter season,” Mao Ning, a spokesperson for China’s foreign ministry, said Friday. “The diseases appear to be less severe and spread with a smaller scale compared to the previous year.”
Apostolopoulos vessel, professor of immunology at the School of Health and Biomedical Sciences of the University Rimite in Australia, said that the number of development cases and tension in physical conditioning systems in densely populated spaces such as China have underlined the need to advance surveillance strategies.
“Ensuring follow -up and responses well timed will be the key to mitigating the dangers of public aptitude of this epidemic,” he said.
Hop